Cognition Therapeutics Inc
CGTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001455365
No open-market purchases or sales by Cognition Therapeutics Inc insiders were filed in the last 90 days; 66 institutions reported holding it in 13F filings for Q2 2026, worth $26.0M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Cognition Therapeutics Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +1 vs. Q1 2022
- Shares held
- 5.19M
- +3.52M (+211.1%) vs. Q1 2022
- Total value
- $11.4M
- +$6.81M (+148.7%) vs. Q1 2022
- New holders
- 7
- 10 more added
- Sold out
- 6
- 7 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $26.0M |
| Q1 2026 | 75 | $16.3M |
| Q4 2025 | 78 | $28.9M |
| Q3 2025 | 68 | $28.7M |
| Q2 2025 | 48 | $3.50M |
| Q1 2025 | 51 | $4.89M |
| Q4 2024 | 45 | $7.78M |
| Q3 2024 | 40 | $1.99M |
| Q2 2024 | 46 | $8.82M |
| Q1 2024 | 47 | $12.9M |
| Q4 2023 | 37 | $13.2M |
| Q3 2023 | 36 | $10.4M |
| Q2 2023 | 35 | $13.0M |
| Q1 2023 | 32 | $14.1M |
| Q4 2022 | 34 | $10.1M |
| Q3 2022 | 31 | $9.67M |
| Q2 2022 | 28 | $11.4M |
| Q1 2022 | 27 | $4.58M |
| Q4 2021 | 20 | $8.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Cognition Therapeutics Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 899 | $2.00K | 0.00% | −2,850−76.0% | Reduced |
| Tower Research Capital LLC (TRC) | 1,907 | $4.00K | 0.00% | +1,907 | New |
| Bray Capital Advisors | 2,250 | $5.00K | 0.00% | +2,250 | New |
| Kestra Advisory Services, LLC | 15,000 | $32.0K | 0.00% | −223,666−93.7% | Reduced |
| Geode Capital Management, LLC | 15,171 | $32.0K | 0.00% | +1,445+10.5% | Added |
| Two Sigma Advisers, LP | 15,600 | $33.0K | 0.00% | −12,500−44.5% | Reduced |
| Bangor Savings Bank | 19,019 | $40.0K | 0.00% | +523+2.8% | Added |
| Baird Financial Group, Inc. | 20,393 | $43.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 21,869 | $46.0K | 0.00% | +21,869 | New |
| BlackRock Inc. | 27,509 | $58.0K | 0.00% | +19,224+232.0% | Added |
| Diligent Investors, LLC | 30,520 | $64.0K | 0.02% | 00.0% | Unchanged |
| B. Riley Financial, Inc. | 30,904 | $65.0K | 0.01% | 00.0% | Unchanged |
| Castle Wealth Management LLC | 43,380 | $92.0K | 0.05% | +43,380 | New |
| Bridgeway Capital Management, LLC | 66,200 | $141.0K | 0.00% | −10,000−13.1% | Reduced |
| Vanguard Group Inc | 70,920 | $150.0K | 0.00% | +12,324+21.0% | Added |
| Wells Fargo & Company | 76,867 | $162.0K | 0.00% | +76,843+320,179.2% | Added |
| Rock Creek Group, LP | 79,751 | $170.0K | 0.02% | +53,312+201.6% | Added |
| Prosight Management, LP | 120,198 | $254.0K | 0.21% | −119,882−49.9% | Reduced |
| Perigon Wealth Management, LLC | 122,846 | $259.0K | 0.02% | +122,846 | New |
| P.A.W. Capital Corp | 135,000 | $285.0K | 0.41% | +15,000+12.5% | Added |
| Nantahala Capital Management, LLC | 192,752 | $407.0K | 0.04% | −3,650−1.9% | Reduced |
| American Financial Group Inc | 205,000 | $432.0K | 0.15% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 214,961 | $453.0K | 0.00% | +201,071+1,447.6% | Added |
| Worth Venture Partners, LLC | 228,170 | $459.0K | 0.28% | +52,804+30.1% | Added |
| Voss Capital, LLC | 309,472 | $653.0K | 0.21% | +283,033+1,070.5% | Added |
| AIGH Capital Management LLC | 910,790 | $2.38M | 0.99% | +910,790 | New |
| Pathstone Family Office, LLC | 2,210,377 | $4.66M | 0.10% | +2,210,377 | New |
| IFP Advisors, Inc | 750 | – | – | −750−50.0% | Reduced |
| Frontier Wealth Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −42,102−100.0% | Sold out |
| New York Life Investments Alternatives | 0 | $0 | 0.00% | −17,667−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −14,536−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,504−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −434−100.0% | Sold out |